Top Biotechnology Startups in 2027

We provide the industry’s only direct-to-consumer healthcare test that analyzes microbial and human gene expressions (mRNA), with technology exclusively licensed from Los Alamos National Lab, in order to provide individuals with health insights and the nutrition they need. By joining Viome, you are joining a revolutionary movement. A movement that – for the first time in human history – will make becoming ill a matter of choice, and not simply bad luck. Scientists have worked for over a decade to develop this technology that offers unprecedented visibility into your body. With this, we can create a unique profile of the biochemistry and ecosystem inside of you, and make personalized, actionable, and adaptive recommendations for your health. Our at-home tests are not just one-time tests, but your true health companion, enabling you to monitor your health over time. Your results and recommendations adapt to your changing ecosystem so you are always aware and taking action towards maximizing your vitality and lifespan. The Viome team is made up of scientists, engineers, researchers and entrepreneurs who are passionate about radically improving the wellness of our customers.

We are building the world's first bone marrow bank to treat blood cancers, improve organ transplantation and repair damage from radiation. the company was founded in 2016 to revolutionise bioengineering, with the ultimate goal of ending disease.

Inquire to learn more about our platform technologies.

Maybe you’ve supported a friend or family member who’s dealing with cancer. Maybe you’ve battled it yourself. At Syapse, our mission is to enable healthcare providers to deliver the best care to every cancer patient through precision medicine and it's our personal connections to this mission that unites us Together, we're building a revolutionary suite of products that integrate complex oncology data and share insights across the cancer care ecosystem including cancer care centers and life science companies developing the next generation of cancer diagnostics and medicines. Join us in our exciting mission to scale precision medicine to reach every cancer patient on the planet. All while making a positive impact in the lives of people battling cancer, their families and the organizations committed to their care.

AbCellera is an antibody discovery and development engine that’s specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic – and patients – sooner. With the integrated AbCellera platform, our experts search a wide range of diverse antibodies to select the most effective and developable leads fast and set our partners up for enduring success.  We have extensive experience forging partnerships with emerging biotechs and leading pharmaceutical companies. AbCellera leverages proprietary hardware, software, tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Seqera empowers scientists to solve today's most complex and important challenges – from pioneering innovative therapeutics to unveiling the secrets of the universe. The journey began with Nextflow — open software that helps over 100,000 global scientists analyze and process data, with more power and flexibility than ever before. Seqera equips scientists with modern software development tools to conduct science faster, on larger datasets, and with more confidence. Accelerating discoveries in an open world.

Tempus is a technology company that has built an operating system to battle cancer. Tempus enables physicians to deliver personalized cancer care through its interactive analytical and machine learning platform. The company provides genomic sequencing services and analyzes molecular and therapeutic data to empower physicians to make real-time, data-driven decisions. Our goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as we gather more data.

Veeva builds enterprise cloud technology that powers the biggest names in the pharmaceutical, biotech, consumer goods, chemical & cosmetics industries. Our customers make vaccines, life-saving medicines, and life-enhancing products that make a difference in everyday lives. Our technology has transformed these industries; enabling them to get critical products and services to market faster. Our core values, Do the Right Thing, Customer Success, Employee Success, and Speed, guide us as we make our customers more efficient and effective in everything they do.

We have created a revolutionary silicon-based DNA synthesis platform, that offers precision at a scale otherwise unavailable to our customers. We provide an innovative silicon-based DNA Synthesis Platform which enables production of high-quality synthetic DNA which is faster and more affordable than ever before. Our platform allows you to work with genes, oligo pools (with CRISPR), variant libraries, DNA data storage and NGS target enrichment.